Transcriptomics

Dataset Information

0

DRG2 is required for cell surface localization of PD-L1 in melanoma cells and optimum response to anti-PD-1 immune checkpoint blockade [bulk RNA-seq]


ABSTRACT: Tumors expressing high level of programmed cell death-1 (PD-1) ligand 1 (PD-L1) are more likely to respond to immune checkpoint blockers (ICBs) targeting PD-1 or PD-L1. However, more than half of tumor patients with high PD-L1 expression does not respond to ICBs and the underlying mechanisms are yet to be clarified. Here we show that depletion of developmentally regulated GTP-binding protein 2 (DRG2) inhibited recycling of endosomal PD-L1 and reduced surface PD-L1 level in melanoma cells. DRG2-depleted cells showed decreased binding with recombinant PD-1. Although DRG2-depleted cells expressed high levels of PD-L1, anti-PD-1 ICB did not activate T cells within DRG2-depleted tumors and failed to improve the survival of DRG2-depleted tumor-bearing mice. Cohort analysis of melanoma patients under anti-PD-1 treatment revealed that patients bearing tumors with high DRG2 protein level were more sensitive to PD-1 anti-PD-1 ICBs. These findings identify DRG2 as a regulator of recycling of endosomal PD-L1 and a key determinant for response to anti-PD-1 ICB and provide insights into how to increase the correlation between PD-L1 expression and response to ICB.

ORGANISM(S): Mus musculus

PROVIDER: GSE231972 | GEO | 2023/11/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-11-06 | GSE231973 | GEO
2023-12-01 | GSE248271 | GEO
2023-07-06 | PXD039710 | Pride
2021-04-20 | GSE172320 | GEO
2021-04-17 | GSE172239 | GEO
2020-08-17 | GSE152925 | GEO
2012-07-09 | E-GEOD-39205 | biostudies-arrayexpress
2022-05-15 | GSE202879 | GEO
2015-05-01 | E-GEOD-65041 | biostudies-arrayexpress
2023-03-11 | PXD037102 | Pride